Why Has Ranitidine Been Withdrawn?
The H 2 Blocker Ranitidine (Zantac) Has Been Withdrawn from the U. S. Market Because of Concerns over Levels of the Contaminant N-Nitrosodimethylamine, Which...
The H 2 blocker ranitidine (Zantac) has been withdrawn from the U.S. market because of concerns over levels of the contaminant N-nitrosodimethylamine, which can increase with time and temperature, posing a risk of cancer. Patients should be told to discard all products containing ranitidine.
Will ranitidine be back on the market?
Zantac will be back on the market when the manufacturer, Sanofi, can confirm to the U.S. Food and Drug Administration (FDA) that the NDMA levels in the drug are stable and do not pose a threat to consumers. Only then will the FDA “consider” making Zantac and other ranitidine products available.
Why was ranitidine taken off the market?
Officials at the Food and Drug Administration (FDA) have ordered all ranitidine medications, sold under the brand name Zantac, taken off store shelves immediately. The order is tied to concerns that the medication may contain a cancer-causing chemical that's also been detected in certain blood pressure medications.
Sarah Jenkins is a veteran tech journalist with over 12 years of experience covering artificial intelligence, mobile innovations, and digital ethics. Her insights have appeared in leading technology publications worldwide.
